BioCentury
ARTICLE | Clinical News

EchoGen injectable ultrasound contrast agent: Filed IND for Phase I trial in 40 patients

January 17, 1994 8:00 AM UTC

Sonus Pharmaceuticals Inc. (Costa Mesa, Calif.) Product: EchoGen injectable ultrasound contrast agent Indication: Imaging the heart and abdominal organs Status: Filed IND for Phase I trial in 40 pati...